Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 30, 2021
Patent Application Number
15932234
Date Filed
August 18, 2016
Patent Primary Examiner
Patent abstract
Melanophilin (MLPH) of the present invention is involved in differentiation into an adipocyte or fat accumulation, and accordingly, obesity can be treated or prevented by inhibiting the MLPH. Further, by measuring an expression level of the MLPH, obesity can be diagnosed and treated, and therapeutic agents for obesity and agents regulating differentiation into adipocytes can be screened.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
